In a report, Oxfam said it made the estimates after analysing deals made by pharmaceutical companies and vaccine producers with countries for the five leading vaccine candidates that are now in Phase-3 clinical trials. The global agency has also warned that the same companies making vaccines might not have the capacity to make enough vaccines for everyone who requires one.
"Even in the extremely unlikely event that all five vaccines succeed, almost two thirds (61 percent) of the world's population will not have a vaccine until at least 2022".
Oxfam is a global movement of people who are fighting inequality to beat poverty together. It said that of these, the supply deals have already been agreed for 5.303 billion [530 crore] doses.
"We urge the MOH to be transparent on its plans to acquire vaccines for the country. We need a People's Vaccine, not a profit vaccine".
The calculations expose a broken system that protects the monopolies and profits of pharmaceutical corporations and favours wealthy nations, while artificially restricting production and leaving most of the world's population waiting longer than necessary for a vaccine. The prices range from $12-16 in the USA per dose and around $35 per dose in other countries.
Big pharma is racing to produce an effective jab to counter a virus that has now killed more than 935,000 people around the world and infected nearly 30 million.
The report said that the United Kingdom has managed to secure deals equal to five doses per person of the country's population. In contrast, Bangladesh has secured only dose per head of its population, it added.
There are also large differences in the willingness of pharmaceutical companies to set aside supply for poorer nations.Читайте также: Trump doubles down on Covid-19 vaccine timeline, contradicting top health official
On Sept 9, Prime Minister Tan Sri Muhyiddin Yassin promised that Malaysia will not miss the vaccine for Covid-19 even though the country does not produce it.
Over half of the future supply of COVID-19 vaccine candidates has already been cornered by a small group of wealthy nation, according to a report by Oxfam International. UNAIDS and other members of the People's Vaccine Alliance are calling for a new approach that puts public health first by sharing knowledge and maximising supply. "Anything short of that will lead to more deaths and economic chaos, forcing millions into destitution".
"The MMA believes even if Malaysia has its own bilateral negotiations for a vaccine, signing up for the Covax Vaccine Plan can be an added option that will guarantee access to vaccines for Covid-19".
Nine potential coronavirus vaccines are now undertaking clinical trials of which, supply deals of five companies have been made public, the report added.
Brazil's central government has an agreement to test and buy the AstraZeneca vaccine, while Sao Paulo state is testing one developed by China's Sinovac Biotech and the states of Paraná and Bahia reached deals for Russia's Sputnik V vaccine.
Countries have until midnight on Friday to formalize legally binding commitments to COVAX, a mechanism for pooled procurement and equitable distribution of eventual vaccines.
A major concern around the eagerly awaited COVID-19 vaccine is the availability of doses and fair distribution across the world, a sentiment that has reportedly been echoed by Melinda Gates. No single corporation will ever be able to meet the world's need for a COVID-19 vaccine.
Therefore Oxfam and other similar organisations across the world are calling for a People's Vaccine, that can be availed by everyone and is free of charge being distributed fairly based on the requirement.При любом использовании материалов сайта и дочерних проектов, гиперссылка на обязательна.
«» 2007 - 2020 Copyright.
Автоматизированное извлечение информации сайта запрещено.
Код для вставки в блог